Current Report Filing (8-k)
February 20 2018 - 4:06PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest
event reported):
February 14, 2018
IDEXX LABORATORIES, INC.
(Exact name of registrant as specified
in its charter)
Delaware
|
000-19271
|
01-0393723
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
|
|
|
One IDEXX Drive, Westbrook, Maine
|
04092
|
(Address of principal executive offices)
|
(ZIP Code)
|
207.556.0300
(Registrant’s telephone number, including
area code)
Not Applicable
(Former name or former address, if changed
since last report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (
see
General Instruction
A.2. below):
¨
Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12)
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b))
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c))
Indicate
by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of
1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging
growth company
¨
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act.
¨
|
I
tem 5.02
|
Departure of Directors or Certain Officers; Election of
Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
|
On
February 14, 2018, Mr. William T. End, a Class I Director, provided IDEXX Laboratories, Inc. (the “Company” or “IDEXX”)
notice of his intention to retire from the Board of Directors (the “Board”) immediately following the expiration of
his term on the date of the Company’s 2018 annual meeting of stockholders to be held on May 9, 2018. Mr. End’s decision to retire from the Board does not arise from any disagreement with the Company on
any matter relating to the Company’s operations, policies or practices.
The
Company thanks Mr. End for his outstanding service, commitment and leadership during his tenure as a member of the IDEXX Board
since 2000, a period during which the Company experienced significant successes and strong growth and created long-term value for
our stockholders.
In
accordance with the Company’s amended and restated by-laws, the Board reduced the size of the Board to eight members and
the size of Class I to two, effective upon Mr. End’s retirement from the Board.
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
IDEXX LABORATORIES, INC.
|
|
|
|
|
|
|
Date: February 20, 2018
|
By:
|
/s/ Jacqueline L. Studer
|
|
|
|
Jacqueline L. Studer
|
|
|
Corporate Vice President, General Counsel and Secretary
|
IDEXX Laboratories (NASDAQ:IDXX)
Historical Stock Chart
From Apr 2024 to May 2024
IDEXX Laboratories (NASDAQ:IDXX)
Historical Stock Chart
From May 2023 to May 2024